documents: FDA-2018-N-3091-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2018-N-3091-0004 | FDA | FDA-2018-N-3091 | Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal; Correction | Notice | Correction | 2023-01-11T05:00:00Z | 2023 | 1 | 2023-01-11T05:00:00Z | 2023-01-11T14:43:10Z | 2023-00390 | 0 | 0 | 09000064855e05c7 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref